Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10310464 | 0.92 | MEN1 (0.33) | MEN1HTTKMT2AALDH1A1 | |
| SCHEMBL10310467 | 0.88 | PRKCA (0.33) | — | |
| SCHEMBL10310446 | 0.78 | — | — | |
| SCHEMBL12941153 | 0.69 | — | — | |
| SCHEMBL10310462 | 0.67 | — | — | |
| SCHEMBL12941154 | 0.66 | PRKCA (0.31) | — | |
| SCHEMBL10310394 | 0.62 | THRB (0.37) | MEN1KMT2AALDH1A1 | |
| SCHEMBL1828803 | 0.61 | MAPT (0.36) | MEN1HTTKMT2A | |
| SCHEMBL647676 | 0.61 | MAPT (0.36) | MEN1HTTKMT2A | |
| SCHEMBL1001848 | 0.61 | MAPT (0.36) | MEN1HTTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2805938-A1 | Bi- or tricyclic sterically hindered alkoxyamines and process for their preparation | BASF SE (DE) | 2014-11-26 | — | — | EP | disclosed |
| US-8809533-B2 | Bi- or tricyclic sterically hindered alkoxyamines and process for their preparation | BASF SE (DE) | 2014-08-19 | — | — | US | disclosed |
| US-8809533-B2 | Bi- or tricyclic sterically hindered alkoxyamines and process for their preparation | BASF SE (DE) | 2014-08-19 | — | — | US | disclosed |
| US-20140039100-A1 | BI - OR TRICYCLIC STERICALLY HINDERED ALKOXYAMINES AND PROCESS FOR THEIR PREPARATION | BASF SE (DE) | 2014-02-06 | — | — | US | disclosed |
| US-20140039100-A1 | BI - OR TRICYCLIC STERICALLY HINDERED ALKOXYAMINES AND PROCESS FOR THEIR PREPARATION | BASF SE (DE) | 2014-02-06 | — | — | US | disclosed |
| US-20120178829-A1 | BI - OR TRICYCLIC STERICALLY HINDERED ALKOXYAMINES AND PROCESS FOR THEIR PREPARATION | BASF SE (DE) | 2012-07-12 | — | — | US | disclosed |
| US-20120178829-A1 | BI - OR TRICYCLIC STERICALLY HINDERED ALKOXYAMINES AND PROCESS FOR THEIR PREPARATION | BASF SE (DE) | 2012-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120178829-A1 | BI - OR TRICYCLIC STERICALLY HINDERED ALKOXYAMINES AND PROCESS FOR THEIR PREPARATION | CAT, SCO2, GPX4 | MEN1 4222/4885HTT 176/4885KMT2A 474/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.